Evidence map›Paper›PMID 27611479›Full record

ArticleBJU international2017

Qualitative study on decision-making by prostate cancer physicians during active surveillance.

Stacy Loeb, Caitlin Curnyn, Angela Fagerlin, Ronald Scott Braithwaite, Mark D Schwartz, Herbert Lepor, Herbert Ballentine Carter, Erica Sedlander

Abstract read
In one paragraph

Article in BJU international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Patient participation in treatment decision-making of prostate cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Biomarkers in active surveillance.Translational andrology and urology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Stacy LoebDepartment of Urology, New York University, New York, NY, USA.
Caitlin CurnynDepartment of Population Health, New York University, New York, NY, USA.
Angela FagerlinDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
Ronald Scott BraithwaiteDepartment of Population Health, New York University, New York, NY, USA.
Mark D SchwartzDepartment of Population Health, New York University, New York, NY, USA.
Herbert LeporDepartment of Urology, New York University, New York, NY, USA.
Herbert Ballentine CarterBrady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA.
Erica SedlanderDepartment of Population Health, New York University, New York, NY, USA.
New York University · USJohns Hopkins Hospital · USVA Salt Lake City Healthcare System · USVeterans Health Administration · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Richard Lewis Possemato · 1985 to 2026
$83.1M
Optimal Strategy for Conservative Management of Prostate CancerK07CA178258 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LOEB, STACY · 2013 to 2017
$889k
NCI NIH HHS K07 CA178258NCI NIH HHS P30 CA016087
6 · The paper itself

Abstract

objectiveTo explore and identify factors that influence physicians' decisions while monitoring patients with prostate cancer on active surveillance (AS). SUBJECTS AND

methodsA purposive sampling strategy was used to identify physicians treating prostate cancer from diverse clinical backgrounds and geographic areas across the USA. We conducted 24 in-depth interviews from July to December 2015, until thematic saturation was reached. The Applied Thematic Analysis framework was used to guide data collection and analysis. Interview transcripts were reviewed and coded independently by two researchers. Matrix analysis and NVivo software were used for organization and further analysis.

resultsEight key themes emerged to explain variation in AS monitoring: (i) physician comfort with AS; (ii) protocol selection; (iii) beliefs about the utility and quality of testing; (iv) years of experience and exposure to AS during training; (v) concerns about inflicting 'harm'; (vi) patient characteristics; (vii) patient preferences; and (viii) financial incentives.

conclusionThese qualitative data reveal which factors influence physicians who manage patients on AS. There is tension between providing standardized care while also considering individual patients' needs and health status. Additional education on AS is needed during urology training and continuing medical education. Future research is needed to empirically understand whether any specific protocol is superior to tailored, individualized care.

Indexed as

Clinical Decision-MakingPhysiciansQualitative ResearchWatchful WaitingAdultAgedAttitude of Health PersonnelHealth Services ResearchHumansMaleMiddle AgedPatient PreferencePhysician-Patient RelationsPractice Patterns, Physicians'Prostatic NeoplasmsUnited Statesactive surveillancemarkersprostate cancerqualitativesurvey

Identifiers

PMID27611479
PMCPMC5555310
OpenAlexW2508311006

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.